Document Detail

Bcl-2 expression in mycosis fungoides before and after PUVA therapy.
MedLine Citation:
PMID:  20415745     Owner:  NLM     Status:  MEDLINE    
PUVA is the first therapeutic choice in early stages of mycosis fungoides (MF). In this study the effect of PUVA on bcl-2 expression in MF was assessed in 15 patients (three stage Ia and 12 stage Ib) and 10 controls. Two biopsies were taken from each patient before and after 24 sessions of PUVA therapy. Histopathological assessment and immunohistochemical staining for bcl-2 was performed and showed positive bcl-2 staining of lymphocytes in 53% of MF cases (8/15) before PUVA, with no statistically significant difference in the bcl-2 level before and after PUVA therapy (P value 0.3). A statistically significant difference was found in the bcl-2 level between control samples and MF patients' biopsies before (P value 0.02) and after PUVA therapy (P value 0.011). In conclusion, a lack of decline in the bcl-2 level and the absence of clinical or histopathological correlation with the bcl-2 level before and after PUVA therapy in MF patients suggest that PUVA-induced apoptosis in MF cases may occur through pathways other than bcl-2 inhibition.
Hani Weshahy; Doa Mahgoub; Nermine El-Eishy; Amira Mohamed El-Tawdy; Dalia Ahmed Bassiouny; Nahla Hunter; Ali Hindawi
Related Documents :
22843135 - Contrast enhanced ultrasound ventriculography.
19210875 - Increased serum levels of cartilage oligomeric matrix protein in patients with psoriasi...
21821015 - Correlation of misfolded transthyretin in abnormal vitreous and high myopia related ocu...
21995405 - Coagulopathy of chronic liver disease.
2398585 - Radical treatment of mal perforans in diabetic patients with arterial insufficiency.
16236275 - Inflammation, complement activation and endothelial function in stable and unstable cor...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Photodermatology, photoimmunology & photomedicine     Volume:  26     ISSN:  1600-0781     ISO Abbreviation:  Photodermatol Photoimmunol Photomed     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-04-26     Completed Date:  2010-07-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9013641     Medline TA:  Photodermatol Photoimmunol Photomed     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  107-9     Citation Subset:  IM    
Department of Dermatology, Kasr El-Aini University Hospital, Cairo University, Cairo, Egypt.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Apoptosis* / drug effects,  radiation effects
Gene Expression Regulation, Neoplastic* / drug effects,  radiation effects
Lymphocytes / pathology
Middle Aged
Mycosis Fungoides / drug therapy,  metabolism*,  pathology
PUVA Therapy*
Proto-Oncogene Proteins c-bcl-2 / biosynthesis*
Skin Neoplasms / drug therapy,  metabolism*,  pathology
Reg. No./Substance:
0/Proto-Oncogene Proteins c-bcl-2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Purpuric lesions induced by UVA1 spectrum (340-400 nm) phototesting in an adult with persistent and ...
Next Document:  Risk factors for suspected developmental delay at age 2 years in a Brazilian birth cohort.